These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 770330)

  • 41. Influence of route of inoculation on anti-Mycobacterium lepraemurium antibody isotypes in murine leprosy.
    Hoffenbach A; Diioro L; Bach MA
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):305-15. PubMed ID: 3298477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth of Mycobacterium lepraemurium in nonstimulated and stimulated mouse peritoneal-derived and bone marrrow-derived macrophages in vitro.
    Alexander J; Smith CC
    Infect Immun; 1978 Dec; 22(3):631-6. PubMed ID: 365762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro cultivation and characterization of Mycobacterium lepraemurium.
    Pattyn SR; Portaels F
    Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):7-14. PubMed ID: 6988351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction and suppression of cross-reactive antituberculosis immunity after Mycobacterium lepraemurium infection of mice.
    Lefford MJ; Logie PS
    Infect Immun; 1981 Mar; 31(3):1023-33. PubMed ID: 6785237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experimental murine leprosy: growth of Mycobacterium lepraemurium in C3H and C57/BL mice after footpad inoculation.
    Closs O
    Infect Immun; 1975 Sep; 12(3):480-9. PubMed ID: 1100521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth of Mycobacterium marinum in the footpads of T-cell-depleted mice.
    Collins FM; Montalbine V; Morrison NE
    Infect Immun; 1975 May; 11(5):1088-93. PubMed ID: 1079017
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancement of the antibody response in vitro by adherent cells from mice infected with Mycobacterium lepraemurium.
    Watson SR; Brown IN; Sljivić VS
    Infect Immun; 1977 Aug; 17(2):263-7. PubMed ID: 330402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. II. Production of interleukins 2, 4, and 6 and of interferon-gamma by draining lymph node cells.
    Roch F; Bach MA
    Clin Immunol Immunopathol; 1991 Sep; 60(3):443-54. PubMed ID: 1907533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimycobacteria antibodies in M. lepraemurium murine infection.
    Bach MA; Hoffenbach A
    Acta Leprol; 1984; 2(2-4):403-11. PubMed ID: 6398599
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haemophagocytosis and other haematological aspects of Mycobacterium lepraemurium disease of mice.
    Resnick M; Ben-Ishay Z; Mor N; Levy L; Bercovier H
    J Comp Pathol; 1988 Jul; 99(1):65-75. PubMed ID: 3062053
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mycobacterium lepraemurium activates macrophages but fails to trigger release of superoxide anion.
    Mor N; Goren MB; Pabst MJ
    J Immunol; 1988 Jun; 140(11):3956-61. PubMed ID: 2836508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Attenuated Mycobacterium lepraemurium vaccine non-protective against Mycobacterium intracellulare infection in mice.
    Nakanishi M
    Hiroshima J Med Sci; 1986 Mar; 35(1):67-9. PubMed ID: 3528063
    [No Abstract]   [Full Text] [Related]  

  • 53. Transitory macrophage activation in the granulomatous lesions of Mycobacterium lepraemurium-induced lepromatoid leprosy in the mouse.
    Rojas-Espinosa O; Vega R; Oltra A; Arce P; Nunez A
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):428-36. PubMed ID: 3047284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulatory interactions between macrophages and T cells in Mycobacterium lepraemurium-specific T-cell activation.
    Brett SJ
    Cell Immunol; 1987 Dec; 110(2):379-90. PubMed ID: 3319191
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies on murine leprosy bacillus. XII. Reproduction test of the diseases in mice using small doses of the thirteenth subculture of the supposed Hawaiian strain of Mycobacterium lepraemurium.
    Ogawa T; Hiraki M
    Kitasato Arch Exp Med; 1974 Dec; 47(4):1-13. PubMed ID: 4619143
    [No Abstract]   [Full Text] [Related]  

  • 56. Evidence for generation of suppressor T cells in Mycobacterium lepraemurium-infected CBA/J mice, a mouse strain highly susceptible to the infection.
    Saito N; Hirooka Y
    Microbiol Immunol; 1983; 27(1):75-85. PubMed ID: 6223201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Observation on the host reaction to the cultivated M. lepraemurium in the spread subcutaneous tissue preparations of mice.
    Matsuoka M; Kawaguchi Y
    Nihon Rai Gakkai Zasshi; 1982; 51(2):96-106. PubMed ID: 6763028
    [No Abstract]   [Full Text] [Related]  

  • 58. Induction of delayed type hypersensitivity against ultrasonicated Mycobacterium lepraemurium bacilli without simultaneous local reactivity against live bacilli or protective immunity.
    Løvik M; Closs O
    Clin Exp Immunol; 1983 Aug; 53(2):319-27. PubMed ID: 6349877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of dose and route of inoculation and of mouse strain on the production of interleukin 2 in mice infected with Mycobacterium lepraemurium.
    Hoffenbach A; Lagrange PH; Bach MA
    Acta Leprol; 1984; 2(2-4):413-20. PubMed ID: 6398600
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Multiplication of Mycobacterium lepraemurium in cell-free liquid medium. 7. Pathogenicity of M. lepraemurium cultivated in NC-5 medium (author's transl)].
    Nakamura M
    Repura; 1975; 44(1):7-12. PubMed ID: 1107724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.